Literature DB >> 12735678

The use of inhaled corticosteroids in the United Kingdom and the Netherlands.

T P van Staa1, C Cooper, H G M Leufkens, J W Lammers, S Suissa.   

Abstract

This study examined the utilisation patterns of inhaled corticosteroids in England/Wales and the Netherlands. Computerised medical records from the GPRD (U.K.) and PHARMO (the Netherlands) databases were used. It included 284733 English/Welsh and 27761 Dutch adult patients who were prescribed inhaled corticosteroids during the 10-year study period. Our results showed that, in both study populations, overall use of inhaled corticosteroids increased over the period studied, with its prevalence rising steeply with age and declining in extreme old age. Decreased use of bronchodilators and oral corticosteroids in the early treatment of asthma was noted in our findings. In addition, a trend towards the decreasing use of oral corticosteroids concomitant with inhaled corticosteroid therapy was also observed for both groups. Our study found that only 42.1% of the GPRD and 31.1% of the PHARMO patients received a repeat prescription within the expected duration ofthe preceding inhaled corticosteroid prescription. In conclusion, our study found many similarities in the prescribing and use of inhaled corticosteroids between the two study populations. The observation of irregular use of inhaled corticosteroid among a substantial number of patients highlights a need for further study into the reasons for irregular use and its consequences on the effectiveness of treatment.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735678     DOI: 10.1053/rmed.2002.1453

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Prescription patterns in asthma patients initiating salmeterol in UK general practice: a retrospective cohort study using the General Practice Research Database (GPRD).

Authors:  Rachael L DiSantostefano; Kourtney J Davis
Journal:  Drug Saf       Date:  2011-06-01       Impact factor: 5.606

2.  Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients.

Authors:  Stefan Ottenbros; Martina Teichert; Romy de Groot; Fabienne Griens; Fong Sodihardjo; Michel Wensing; J J de Gier
Journal:  Int J Clin Pharm       Date:  2013-12-01

3.  Patients' understanding of the reasons for starting and discontinuing inhaled corticosteroids.

Authors:  Tanja T Menckeberg; Marcel L Bouvy; Madelon Bracke; Jacqueline G Hugtenburg; Jan-Willem Lammers; Jan A M Raaijmakers
Journal:  Br J Clin Pharmacol       Date:  2008-08       Impact factor: 4.335

4.  LABA monotherapy in asthma: an avoidable problem.

Authors:  Daniel R Morales
Journal:  Br J Gen Pract       Date:  2013-12       Impact factor: 5.386

5.  Knowledge of actions of inhaled corticosteroids in patients who did not persist drug treatment early.

Authors:  Tanja T Menckeberg; Jacqueline G Hugtenburg; Jan Willem Lammers; Jan A M Raaijmakers; Marcel L Bouvy
Journal:  Int J Clin Pharm       Date:  2012-04

6.  Systematic Evaluation of Corticosteroid Use in Obese and Non-obese Individuals: A Multi-cohort Study.

Authors:  Mesut Savas; Vincent L Wester; Sabine M Staufenbiel; Jan W Koper; Erica L T van den Akker; Jenny A Visser; Aart J van der Lely; Brenda W J H Penninx; Elisabeth F C van Rossum
Journal:  Int J Med Sci       Date:  2017-06-13       Impact factor: 3.738

7.  Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol.

Authors:  Conor P Woods; Nicola Argese; Matthew Chapman; Christopher Boot; Rachel Webster; Vijay Dabhi; Ashley B Grossman; Andrew A Toogood; Wiebke Arlt; Paul M Stewart; Rachel K Crowley; Jeremy W Tomlinson
Journal:  Eur J Endocrinol       Date:  2015-08-20       Impact factor: 6.664

Review 8.  Supported self-management for asthma.

Authors:  Hilary Pinnock
Journal:  Breathe (Sheff)       Date:  2015-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.